For: | Lazzeri C, Valente S, Chiostri M, D’Alfonso MG, Gensini GF. Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction. World J Cardiol 2014; 6(4): 140-147 [PMID: 24772254 DOI: 10.4330/wjc.v6.i4.140] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v6/i4/140.htm |
Number | Citing Articles |
1 |
Marija Vavlukis, Biljana Zafirovska, Emilija Antova, Bekim Pocesta, Enes Shehu, Hajber Taravari, Irena Kotlar, Darko Kitanovski, Danica Petkoska, Ivan Vasilev, Filip Janusevski, Ivica Bojovski, Sashko Kedev. The Impact of Glyco-Metabolic Status in Patients Treated for Acute Coronary Syndrome. PRILOZI 2018; 39(1): 37 doi: 10.2478/prilozi-2018-0022
|
2 |
Sebastian T. Lugg, Christine J. H. May, Peter Nightingale, Robbie P. E. Tuffley, June Al-Hourani, Parijat De. HbA1c screening for new onset diabetes following acute coronary syndrome: is it a worthwhile test in clinical practice?. Journal of Diabetes & Metabolic Disorders 2017; 16(1) doi: 10.1186/s40200-017-0296-4
|
3 |
Ivana Škrlec, Jakov Milić, Ines Cilenšek, Daniel Petrovič, Jasenka Wagner, Borut Peterlin. Circadian clock genes and myocardial infarction in patients with type 2 diabetes mellitus. Gene 2019; 701: 98 doi: 10.1016/j.gene.2019.03.038
|
4 |
Sergey V. Kakorin, Ruben A. Iskandaryan, Ashot M. Mkrtumyan. Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials. Diabetes mellitus 2016; 19(2): 141 doi: 10.14341/DM200412-6
|
5 |
Mustafa Karakurt, Burak Acar, Ozcan Ozeke, Mustafa Bilal Ozbay, Yasin Ozen, Mustafa Karanfil, Sefa Unal, Cagri Yayla, Serkan Cay, Orhan Maden, Dursun Aras, Serkan Topaloglu, Sinan Aydogdu, Zehra Golbasi. Advantages and Pitfalls of the Glycated Hemoglobin A1c Measurement in Acute Coronary Syndrome: Start Simple, Evolve to More Sophisticated. Angiology 2019; 70(2): 182 doi: 10.1177/0003319718800570
|